PAPAVERINE / PHENTOLAMINE / PROSTAGLANDIN 150MG / 2.5MG / 50MCG SOLUTION, 5 mL vials, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS 39402
Published November 9, 2022 · Recall initiated: October 7, 2022
Summary
FDA records drug Class II recall D-0042-2023, published November 9, 2022 and initiated October 7, 2022. Recalling firm: Pharmacy Plus, Inc. dba Vital Care Compounder; Status: Ongoing; Reported quantity: 56 vials; Lot: Lots: 64409, BUD: 04/08/2023; 60849, BUD: 05/23/2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.
What to do
Voluntary: Firm initiated · Telephone
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Pharmacy Plus, Inc. dba Vital Care Compounder
- Distributor
- AL, LA, MS, and TN
- Lot
- Lots: 64409, BUD: 04/08/2023; 60849, BUD: 05/23/2023
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAC-Semaglutide 5mg/mL injection, 0.5mL vials, Rx only, Vital Care Compounder 115 South 40th Ave, Suite AApril 26, 2023
- FDAPAPAVERINE HCL STOCK SOLUTION 30MG/ML SOLUTION, 10 mL vial, Rx only, Vital Care Compounder, 115 S. 40th Ave.,November 9, 2022
- FDAGLYCERIN OPHTHALMIC DROPS 98.5% Solution, 10 mL droptainer, Rx only, Vital Care Compounder, 115 S. 40th Ave.,November 9, 2022
- FDAMOXIFLOXACIN PRESERVATIVE FREE SYR, 0.15 mg/0.1 mL, Sterile Solution, 1 mL syringes, Rx only, Vital CareNovember 9, 2022
- FDAPAP/PHEN/PROSTAG/ATROPINE INJ 150MG/7.5MG/75MCG/1MG bottle solution, 5 mL vials, Rx only, Vital CareNovember 9, 2022
- FDAPAPAVERINE / PHENTOLAMINE / PROSTAGLANDIN INJ 150MG/10MG/100MCG/ BOTTLE SOLUTION, 5 ML vial, Rx only, VitalNovember 9, 2022
Questions about this recall
Was PAPAVERINE / PHENTOLAMINE / PROSTAGLANDIN 150MG / 2.5MG / 50MCG SOLUTION, 5 mL vials, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS 39402 recalled?
Yes. FDA published recall D-0042-2023 on November 9, 2022. Reported hazard: Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.
What should I do if I have this product?
Voluntary: Firm initiated · Telephone